These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 19951711)
1. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells. Yoshida J; Ishibashi T; Yang M; Nishio M Life Sci; 2010 Jan; 86(3-4):124-32. PubMed ID: 19951711 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of amlodipine, a Ca2+ channel blocker, on human epidermoid carcinoma A431 cells in vitro and in vivo. Yoshida J; Ishibashi T; Nishio M Eur J Pharmacol; 2004 May; 492(2-3):103-12. PubMed ID: 15178352 [TBL] [Abstract][Full Text] [Related]
3. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells. Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406 [TBL] [Abstract][Full Text] [Related]
4. G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells. Yoshida J; Ishibashi T; Nishio M Biochem Pharmacol; 2007 Apr; 73(7):943-53. PubMed ID: 17217918 [TBL] [Abstract][Full Text] [Related]
5. Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor. Yoshida J; Ishibashi T; Nishio M Cancer Res; 2001 Aug; 61(16):6151-7. PubMed ID: 11507066 [TBL] [Abstract][Full Text] [Related]
6. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors. Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602 [TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway. Gu D; Li H; Wang Z; Chen Q; Jiang J; Zhu H Laryngoscope; 2007 Oct; 117(10):1782-9. PubMed ID: 17906498 [TBL] [Abstract][Full Text] [Related]
9. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer. Younes MN; Yazici YD; Kim S; Jasser SA; El-Naggar AK; Myers JN Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3425-34. PubMed ID: 16740767 [TBL] [Abstract][Full Text] [Related]
10. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Fan Z; Masui H; Altas I; Mendelsohn J Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927 [TBL] [Abstract][Full Text] [Related]
11. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis. Viloria-Petit A; Crombet T; Jothy S; Hicklin D; Bohlen P; Schlaeppi JM; Rak J; Kerbel RS Cancer Res; 2001 Jul; 61(13):5090-101. PubMed ID: 11431346 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 acts as a tumor suppressor by down-regulating epidermal growth factor receptor-mitogen-activated protein kinase signaling pathway in pancreatic carcinoma cell lines. Han F; Gu D; Chen Q; Zhu H Pancreas; 2009 Oct; 38(7):766-74. PubMed ID: 19893453 [TBL] [Abstract][Full Text] [Related]
13. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor. Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960 [TBL] [Abstract][Full Text] [Related]
14. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Wang XQ; Yan Q; Sun P; Liu JW; Go L; McDaniel SM; Paller AS Cancer Res; 2007 Oct; 67(20):9986-95. PubMed ID: 17942932 [TBL] [Abstract][Full Text] [Related]
15. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line. Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R Cancer Res; 1991 Jan; 51(1):150-6. PubMed ID: 1703031 [TBL] [Abstract][Full Text] [Related]
16. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells. Johnson FM; Saigal B; Donato NJ J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells. Liang M; Garrison JC Mol Pharmacol; 1992 Nov; 42(5):743-52. PubMed ID: 1435749 [TBL] [Abstract][Full Text] [Related]
20. Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41. Matheson SL; McNamee JP; Jean-Claude BJ Cancer Chemother Pharmacol; 2003 Jan; 51(1):11-20. PubMed ID: 12497201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]